fibrinolysis

(redirected from Fibrinolytic agents)
Also found in: Dictionary, Medical, Encyclopedia.
Related to Fibrinolytic agents: Vasodilators, heparin, Percutaneous coronary intervention, fibrinolytic therapy
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Words related to fibrinolysis

a normal ongoing process that dissolves fibrin and results in the removal of small blood clots

References in periodicals archive ?
Several thrombolytic or fibrinolytic agents have been in use in the past few years, of which 3 thrombolytic agents (streptokinase, tissue plasminogen activator, and urokinase) have been studied in a limited fashion in relation to neuraxial anesthesia.
16 Antiplatelet Drugs, Anticoagulants and Fibrinolytic Agents.
Fibrinolytic agents are most effective when administered within 2 to 3 hours from symptom onset (12-15) with longer treatment delays leading to worse clinical outcomes (16).
The first eight chapters describe the pharmacology and clinical utility of common antiplatelet, antithrombin, and fibrinolytic agents, including aspirin, the thieneopyridines, glycoprotein IIb/IIIa inhibitors, unfractionated heparin, the low-molecular weight heparins, and direct thrombin inhibitors.
The use of various fibrinolytic agents (streptokinase, urokinase, and recombinant tissue-type plasminogen activator [rt-PA]) has been reported in a small number of clinical series with a very limited number of participants, yielding significant variability regarding inclusion criteria, treatment protocol, and outcome analysis.
Therapy for necrobiosis lipoidica diabeticorum Therapy Reference number Steroids (systemic, topical, intralesional) 9-11 Platelet aggregation inhibitors (aspirin, 12 dipyridamole) Fibrinolytic agents (pentoxifylline) 13 Chloroquine 14 Psoralen + ultraviolet A phototherapy 15 Granulocyte-macrophage colony-stimulating factor 16 Hyperbaric oxygen 17
Therefore, genotyping of this polymorphism may become relevant to risk assessment and to the selection and dosing of patients being treated with anticoagulant and fibrinolytic agents, in particular with tissue plasminogen activator.
Thrombolysis with various fibrinolytic agents has been described in cases with occluded shunts, as an alternative or adjuvant therapy to balloon angioplasty.
When compared with older fibrinolytic agents, RETAVASE distinguishes itself by its ease of administration - a simple two-bolus injection given 30 minutes apart.